These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10224078)

  • 41. Differential temperature dependence of tobacco etch virus and rhinovirus 3C proteases.
    Raran-Kurussi S; Tözsér J; Cherry S; Tropea JE; Waugh DS
    Anal Biochem; 2013 May; 436(2):142-4. PubMed ID: 23395976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification and characterization of a 3C-like protease from rabbit hemorrhagic disease virus, a calicivirus.
    Boniotti B; Wirblich C; Sibilia M; Meyers G; Thiel HJ; Rossi C
    J Virol; 1994 Oct; 68(10):6487-95. PubMed ID: 8083986
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NMR solution structures of the apo and peptide-inhibited human rhinovirus 3C protease (Serotype 14): structural and dynamic comparison.
    Bjorndahl TC; Andrew LC; Semenchenko V; Wishart DS
    Biochemistry; 2007 Nov; 46(45):12945-58. PubMed ID: 17944485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Peptidyl diazomethyl ketones inhibit the human rhinovirus 3C protease: effect on virus yield by partial block of P3 polyprotein processing.
    Murray MA; Janc JW; Venkatraman S; Babé LM
    Antivir Chem Chemother; 2001 Sep; 12(5):273-81. PubMed ID: 11900346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of active-site residues in protease 3C of hepatitis A virus by site-directed mutagenesis.
    Gosert R; Dollenmaier G; Weitz M
    J Virol; 1997 Apr; 71(4):3062-8. PubMed ID: 9060667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of human rhinovirus-14 3C protease.
    Wang QM; Johnson RB
    Virology; 2001 Feb; 280(1):80-6. PubMed ID: 11162821
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant poliovirus 3C protease. The enzyme application to protein specific fragmentation.
    Sablina EP; Antonov VK
    FEBS Lett; 1991 Jun; 283(2):291-4. PubMed ID: 1646125
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of further proteolytic cleavage sites in the Southampton calicivirus polyprotein by expression of the viral protease in E. coli.
    Liu BL; Viljoen GJ; Clarke IN; Lambden PR
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():291-296. PubMed ID: 10073687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Design of a Human Rhinovirus-14 3C Protease-Inducible Caspase-3.
    Wagner HJ; Weber W
    Molecules; 2019 May; 24(10):. PubMed ID: 31117169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A high capacity microbial screen for inhibitors of human rhinovirus protease 3C.
    McCall JO; Kadam S; Katz L
    Biotechnology (N Y); 1994 Oct; 12(10):1012-6. PubMed ID: 7765405
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitory antibodies identify unique sites of therapeutic vulnerability in rhinovirus and other enteroviruses.
    Meng B; Lan K; Xie J; Lerner RA; Wilson IA; Yang B
    Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13499-13508. PubMed ID: 32467165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Shutoff of RNA polymerase II transcription by poliovirus involves 3C protease-mediated cleavage of the TATA-binding protein at an alternative site: incomplete shutoff of transcription interferes with efficient viral replication.
    Kundu P; Raychaudhuri S; Tsai W; Dasgupta A
    J Virol; 2005 Aug; 79(15):9702-13. PubMed ID: 16014932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deamidations in recombinant human phenylalanine hydroxylase. Identification of labile asparagine residues and functional characterization of Asn --> Asp mutant forms.
    Carvalho RN; Solstad T; Bjørgo E; Barroso JF; Flatmark T
    J Biol Chem; 2003 Apr; 278(17):15142-52. PubMed ID: 12554741
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel point mutation (L70P) inactivates poliovirus 3C protease.
    Uma M; Hegde SR; Rao PP; Nagalekshmi K; Gauthami S; Kumar D; Hegde NR
    Acta Virol; 2018; 62(1):68-77. PubMed ID: 29521105
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human rhinovirus 3C protease as a potential target for the development of antiviral agents.
    Wanga QM; Chen SH
    Curr Protein Pept Sci; 2007 Feb; 8(1):19-27. PubMed ID: 17305557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutations in the poliovirus 3CD proteinase S1-specificity pocket affect substrate recognition and RNA binding.
    Blair WS; Nguyen JH; Parsley TB; Semler BL
    Virology; 1996 Apr; 218(1):1-13. PubMed ID: 8615011
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulation of poliovirus 3C protease by the 2C polypeptide.
    Banerjee R; Weidman MK; Echeverri A; Kundu P; Dasgupta A
    J Virol; 2004 Sep; 78(17):9243-56. PubMed ID: 15308719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rhinovirus 3C protease can localize in the nucleus and alter active and passive nucleocytoplasmic transport.
    Ghildyal R; Jordan B; Li D; Dagher H; Bardin PG; Gern JE; Jans DA
    J Virol; 2009 Jul; 83(14):7349-52. PubMed ID: 19403669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Poliovirus protease 3C mediates cleavage of microtubule-associated protein 4.
    Joachims M; Harris KS; Etchison D
    Virology; 1995 Aug; 211(2):451-61. PubMed ID: 7645249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical characterization of recombinant Avihepatovirus 3C protease and its localization.
    Sun D; Wang M; Wen X; Mao S; Cheng A; Jia R; Yang Q; Wu Y; Zhu D; Chen S; Liu M; Zhao X; Zhang S; Chen X; Liu Y; Yu Y; Zhang L
    Virol J; 2019 Apr; 16(1):54. PubMed ID: 31036013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.